Quentin S. Blackford I Rhythm Technologies, Inc. (IRTC) insider trading activity

Quentin S. Blackford is President and CEO of iRhythm Technologies, Inc.. Currently has a direct ownership of 179,038 shares of IRTC, which is worth approximately $33.4 Million. The most recent transaction as insider was on Aug 05, 2025, when has been sold 30,000 shares (Common Stock) at a price of $161.97 per share, resulting in proceeds of $4,859,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 179K

14.35% 3M change

1.68% 12M change

Total Value Held $33.4 Million

Quentin S. Blackford Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2025	SELL Open market or private sale	$4,859,100 $161.97 p/Share	30,000 Reduced 14.35%	179,038 Common Stock
May 30 2025	BUY Grant, award, or other acquisition	$21,223 $71.46 p/Share	297 Added 0.14%	209,038 Common Stock
Mar 03 2025	SELL Open market or private sale	$885,931 $108.77 p/Share	8,145 Reduced 3.76%	208,741 Common Stock
Feb 26 2025	SELL Open market or private sale	$2,495,116 $112.13 p/Share	22,252 Reduced 9.31%	216,886 Common Stock
Feb 26 2025	BUY Grant, award, or other acquisition	-	38,599 Added 13.9%	239,138 Common Stock
Feb 25 2025	BUY Grant, award, or other acquisition	-	40,610 Added 16.84%	200,539 Common Stock
Nov 04 2024	SELL Open market or private sale	$1,249,784 $77.41 p/Share	16,145 Reduced 9.17%	159,929 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	$20,994 $74.98 p/Share	280 Added 0.16%	176,074 Common Stock
Mar 04 2024	SELL Open market or private sale	$469,121 $111.14 p/Share	4,221 Reduced 2.34%	175,794 Common Stock
Feb 29 2024	SELL Open market or private sale	$3,012,533 $121.96 p/Share	24,701 Reduced 12.07%	180,015 Common Stock
Feb 28 2024	BUY Grant, award, or other acquisition	-	30,938 Added 13.13%	204,716 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	45,268 Added 20.67%	173,778 Common Stock
Jun 06 2023	BUY Grant, award, or other acquisition	$997,643 $102.27 p/Share	9,755 Added 7.06%	128,510 Common Stock
Feb 27 2023	BUY Grant, award, or other acquisition	-	28,775 Added 19.54%	118,524 Common Stock
Nov 02 2022	SELL Open market or private sale	$1,528,070 $120.33 p/Share	12,699 Reduced 12.45%	89,280 Common Stock
Oct 05 2021	BUY Grant, award, or other acquisition	-	101,979 Added 50.0%	101,979 Common Stock

Also insider at

DXCM

DEXCOM INC Healthcare

Chief Operating Officer

AXGN

Axogen, Inc. Healthcare

Director

ATEC

Alphatec Holdings, Inc. Healthcare

FNA

Paragon 28, Inc. Healthcare

QSB